Chord Energy stock price target raised by BofA Securities to $123

Chord Energy (CHRD) is strategically expanding its portfolio with a $550 million acquisition of Williston Basin assets from XTO Energy, projected to add 9 mboed (78% oil) of low-decline production and be financed with low leverage (0.5x-0.6x post-transaction). This acquisition, despite mixed Q2 2025 financials, has prompted BofA Securities to raise its price target to $123 with a Buy rating, echoed by similar upgrades from UBS and Piper Sandler, though it will adjust CHRD's capital return strategy from over 75% to 50%+. This indicates a rebalancing of capital allocation towards growth while maintaining strong analyst confidence.

Analysis

Chord Energy (CHRD) is executing a strategic pivot towards growth, underscored by its $550 million acquisition of Williston Basin assets from XTO Energy. This bolt-on deal is poised to add 9 mboed of low-decline (23%), oil-heavy (78%) production, enhancing the stability of the company's cash flow profile. The transaction is being financed prudently with cash and revolver capacity, maintaining a low pro-forma adjusted net leverage between 0.5x and 0.6x. This strategic investment comes at the cost of a reduced capital return framework, which will shift from 75%+ to 50%+, indicating a reallocation of capital from immediate shareholder returns to long-term asset base expansion. The move has been met with largely positive sentiment from analysts, with BofA, UBS, and Piper Sandler raising price targets to $123, $130, and $169 respectively. This bullish consensus, however, is tempered by the company's mixed Q2 2025 results, which saw a 12.38% revenue beat but a 7.73% miss on EPS ($1.79 actual vs. $1.94 forecast), and a dissenting 'Hold' rating from TD Cowen with a $105 price target. The positive analyst reaction suggests the market is prioritizing the long-term accretive nature of the acquisition over the recent earnings miss and the moderated capital return policy.

Key Decisions for Investors

• Investors should weigh the long-term growth potential from the accretive, low-decline asset acquisition against the immediate reduction in the capital return framework from over 75% to over 50%.
• Monitor near-term execution and integration of the new assets, as the recent Q2 EPS miss and a dissenting 'Hold' rating from TD Cowen introduce a note of caution to the otherwise bullish analyst consensus.
• Given the stock's price of $106.54, which is below the majority of analyst targets but above TD Cowen's, consider the current valuation as a potential entry point for a growth-oriented thesis, while acknowledging the downside risk highlighted by the mixed earnings.
• The conservative financing of the acquisition, maintaining net leverage at a low 0.5x-0.6x, should be viewed as a significant de-risking factor that supports balance sheet stability during this strategic pivot.